CA Patent

CA2591666A1 — Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride

Assigned to Teva Pharmaceutical Fine Chemicals SRL · Expires 2006-07-20 · 20y expired

What this patent protects

A process for the preparation of memantine hydrochloride, intermediates thereof and its hydrochloric acid form are provided.

USPTO Abstract

A process for the preparation of memantine hydrochloride, intermediates thereof and its hydrochloric acid form are provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA2591666A1
Jurisdiction
CA
Classification
—
Expires
2006-07-20
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Fine Chemicals SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.